Vanguard Group Inc Decibel Therapeutics, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.08 - $4.79 $31,243 - $71,950	15,021 Added 2.39%	642,325 $1.94 Million
Q4 2022 Feb 10, 2023	BUY	$1.86 - $3.54 $8,122 - $15,459	4,367 Added 0.7%	627,304 $1.29 Million
Q1 2022 May 13, 2022	SELL	$2.83 - $5.03 $5,263 - $9,355	-1,860 Reduced 0.3%	622,937 $1.89 Million
Q4 2021 Feb 14, 2022	SELL	$4.57 - $8.58 $1,910 - $3,586	-418 Reduced 0.07%	624,797 $2.91 Million
Q3 2021 Nov 12, 2021	BUY	$6.6 - $9.04 $1.67 Million - $2.29 Million	253,441 Added 68.17%	625,215 $4.82 Million
Q2 2021 Aug 13, 2021	BUY	$6.39 - $11.51 $2.38 Million - $4.28 Million	371,774 New	371,774 $3.2 Million

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.